Pancreatic Cancer Research

ResearcherSamsung Medical CenterNo recent work listed

Jun Ho Yi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1499-7131; OpenAlex author ID A5049386904. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper

Papers 3

  1. Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine. Co-author DOI 10.2217/pgs.12.82↗
  2. Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy. Co-author DOI 10.1158/1535-7163.mct-11-0269↗
  3. A prognostic model to predict clinical outcomes with first-line gemcitabine-based chemotherapy in advanced pancreatic cancer. Co-author DOI 10.1159/000328449↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Young Suk Park · 3 shared papers, 2011–2012 · strength 0.08
  2. Joon Oh Park · 3 shared papers, 2011–2012 · strength 0.08
  3. Kee‐Taek Jang · 2 shared papers, 2011–2012 · strength 0.05
  4. Ho Yeong Lim · 2 shared papers, 2011 · strength 0.04
  5. Soo‐Youn Lee · 1 shared paper, 2012 · strength 0.03
  6. Hye In Woo · 1 shared paper, 2012 · strength 0.03
  7. Seonwoo Kim · 1 shared paper, 2012 · strength 0.03
  8. Hye-Lim Jang · 1 shared paper, 2011 · strength 0.02
  9. Seung Tae Kim · 1 shared paper, 2011 · strength 0.02
  10. Dong Wook Choi · 1 shared paper, 2011 · strength 0.02
  11. Kyu Taek Lee · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.